API-BIOXAL, 886 MG/G POWDER FOR IN-HIVE USE

Riik: Iirimaa

keel: inglise

Allikas: HPRA (Health Products Regulatory Authority)

Toimeaine:

OXALIC ACID DIHYDRATE

Saadav alates:

Chemicals Laif S.P.A

ATC kood:

QP53AG03

INN (Rahvusvaheline Nimetus):

OXALIC ACID DIHYDRATE

Annus:

886.0 mg/g

Ravimvorm:

Powder for Syrup

Retsepti tüüp:

LM-Licensed Merchant

Terapeutiline rühm:

Bees

Terapeutiline ala:

Oxalic acid

Näidustused:

Ectoparasiticide

Volitamisolek:

Authorised

Loa andmise kuupäev:

2017-04-07

Toote omadused

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
API-Bioxal, 886 mg/g powder for in-hive use
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
ACTIVE SUBSTANCE:
Oxalic acid dihydrate
886 mg (equal to 632.70 mg of anhydrous)
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Powder for in-hive use.
White fine powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Honey bees_ (Apis mellifera_)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Bees (_Apis mellifera_)
Treatment of varroosis (_Varroa destructor_, parasite of_ Apis
mellifera_).
4.3 CONTRAINDICATIONS
None
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
For greatest efficacy, the product should only be used when the
quantity of brood in the colony is non-existent or at its
lowest levels.
Oxalic acid does not penetrate wax so will not kill mites within
capped brood and therefore the presence
of brood may noticeably reduce the efficacy of the product.
As such, the product should be used in winter or following
manipulation of the colony to produce a broodless state in summer
(e.g.
by queen caging).
With regard to summer
treatments following queen caging, highest levels of efficacy were
achieved when a caging period of at least 25 days
was used, at which point the colonies were completely broodless.
Despite proper treatment, seriously damaged colonies
may not survive due to the effects of varroa infestation.
INTEGRATED PEST MANAGEMENT
The efficacy may vary between colonies
due to the conditions
of
use (residue presence of
brood,
temperature,
reinfestations etc.).
The product
should therefore be used as a treatment
amongst
others within an Integrated Pest
Management program, and mite drop regularly monitored.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_